Lv6
2450 积分 2023-03-12 加入
Protein degraders push into novel target space
5小时前
已完结
Targeting CDK2 to combat drug resistance in cancer therapy
18天前
已完结
The New Frontier: Merging Molecular Glue Degrader and Antibody–Drug Conjugate Modalities To Overcome Strategic Challenges
21天前
已完结
Development of Novel Phosphonodifluoromethyl-Containing Phosphotyrosine Mimetics and a First-In-Class, Potent, Selective, and Bioavailable Inhibitor of Human CDC14 Phosphatases
21天前
已完结
X-ray Characterization and Structure-Based Optimization of Striatal-Enriched Protein Tyrosine Phosphatase Inhibitors
21天前
已完结
Aromatic phosphonates inhibit the lysophospholipase D activity of autotaxin
21天前
已完结
Opportunities and challenges for targeting HPK1 in cancer immunotherapy
1个月前
已完结
Discovery of 1(2H)-phthalazinone and 1(2H)-isoquinolinone derivatives as potent hematopoietic progenitor kinase 1 (HPK1) inhibitors
1个月前
已完结
RIPTACs: A groundbreaking approach to drug discovery
1个月前
已完结
Precision therapeutics and emerging strategies for HR-positive metastatic breast cancer
1个月前
已完结
皖公网安备34019202002308
